Exelixis (NDAQ:EXEL) Moves On Suntrust Robinson Initiation with $33.00 Target; Castleark Management Decreased U S Silica Hldgs (SLCA) Stake

July 17, 2017 - By Hazel Jackson

Castleark Management Llc decreased U S Silica Hldgs Inc (SLCA) stake by 21.61% reported in 2016Q4 SEC filing. Castleark Management Llc sold 89,905 shares as U S Silica Hldgs Inc (SLCA)’s stock declined 29.01%. The Castleark Management Llc holds 326,220 shares with $18.49M value, down from 416,125 last quarter. U S Silica Hldgs Inc now has $2.82 billion valuation. The stock increased 2.51% or $0.83 on July 14, reaching $33.92. About shares traded. U.S. Silica Holdings Inc (NYSE:SLCA) has risen 57.03% since July 17, 2016 and is uptrending. It has outperformed by 40.33% the S&P500.

Among 4 analysts covering Exelixis Inc (NDAQ:EXEL), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Exelixis Inc has $33 highest and $28 lowest target. $30.50’s average target is 14.06% above currents $26.74 stock price. Exelixis Inc had 6 analyst reports since March 31, 2017 according to SRatingsIntel. The firm earned “Market Perform” rating on Monday, April 24 by Oppenheimer. The rating was maintained by Needham with “Buy” on Monday, April 3. The firm has “Buy” rating given on Friday, July 14 by Suntrust Robinson. Needham initiated the shares of EXEL in report on Friday, March 31 with “Buy” rating. The firm has “Outperform” rating by William Blair given on Monday, June 26. The stock of Exelixis, Inc. (NASDAQ:EXEL) has “Market Perform” rating given on Friday, May 5 by Oppenheimer.

Since February 1, 2017, it had 0 insider buys, and 22 sales for $28.28 million activity. MARCHESI VINCENT T sold 10,000 shares worth $213,000. WILLSEY LANCE also sold $228,600 worth of Exelixis, Inc. (NASDAQ:EXEL) on Wednesday, March 15. $216,600 worth of stock was sold by PAPADOPOULOS STELIOS on Monday, March 20. Hessekiel Jeffrey sold $144,702 worth of stock or 6,884 shares. The insider MORRISSEY MICHAEL sold $4.62M. Another trade for 5,000 shares valued at $92,300 was sold by Haley Patrick J.. WYSZOMIERSKI JACK L sold $111,086 worth of Exelixis, Inc. (NASDAQ:EXEL) on Friday, March 31.

Exelixis, Inc. is a biopharmaceutical company. The company has market cap of $7.87 billion. The Firm is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. It has a 2496.73 P/E ratio. The Company’s cabozantinib product is an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors.

Investors sentiment decreased to 1.04 in 2016 Q4. Its down 1.03, from 2.07 in 2016Q3. It turned negative, as 21 investors sold Exelixis, Inc. shares while 78 reduced holdings. 40 funds opened positions while 63 raised stakes. 232.36 million shares or 7.60% more from 215.94 million shares in 2016Q3 were reported. Principal Financial Group holds 0% in Exelixis, Inc. (NASDAQ:EXEL) or 155,076 shares. Moreover, Cam Holdings A S has 0.13% invested in Exelixis, Inc. (NASDAQ:EXEL) for 464,228 shares. California-based Endurant Cap Mgmt Ltd Partnership has invested 0.38% in Exelixis, Inc. (NASDAQ:EXEL). Deutsche State Bank Ag holds 0.01% of its portfolio in Exelixis, Inc. (NASDAQ:EXEL) for 822,355 shares. Tiaa Cref Inv Management Llc owns 1.24 million shares or 0.01% of their US portfolio. Teacher Retirement System Of Texas invested in 0% or 18,447 shares. Stevens Capital L P holds 0.08% in Exelixis, Inc. (NASDAQ:EXEL) or 136,975 shares. Guggenheim Ltd Liability Co owns 261,433 shares. Td Asset Management Inc holds 231,968 shares or 0.01% of its portfolio. Commerzbank Aktiengesellschaft Fi has 0% invested in Exelixis, Inc. (NASDAQ:EXEL) for 11,337 shares. Parametric Port Assocs Limited Liability Com accumulated 297,442 shares. Landscape Capital Lc has invested 0.3% in Exelixis, Inc. (NASDAQ:EXEL). Trexquant Invest Limited Partnership reported 55,600 shares. Cutler Management Lc holds 0.29% or 42,000 shares in its portfolio. Two Sigma Lc has 0.08% invested in Exelixis, Inc. (NASDAQ:EXEL) for 16,445 shares.

Analysts await Exelixis, Inc. (NASDAQ:EXEL) to report earnings on August, 2 after the close. They expect $0.03 EPS, up 118.75% or $0.19 from last year’s $-0.16 per share. EXEL’s profit will be $8.83 million for 222.83 P/E if the $0.03 EPS becomes a reality. After $0.05 actual EPS reported by Exelixis, Inc. for the previous quarter, Wall Street now forecasts -40.00% negative EPS growth.

The stock increased 0.60% or $0.16 on July 14, reaching $26.74. About shares traded. Exelixis, Inc. (NDAQ:EXEL) has risen 266.48% since July 17, 2016 and is uptrending. It has outperformed by 249.78% the S&P500.

Analysts await U.S. Silica Holdings Inc (NYSE:SLCA) to report earnings on July, 31 after the close. They expect $0.36 earnings per share, up 311.76% or $0.53 from last year’s $-0.17 per share. SLCA’s profit will be $29.93 million for 23.56 P/E if the $0.36 EPS becomes a reality. After $0.09 actual earnings per share reported by U.S. Silica Holdings Inc for the previous quarter, Wall Street now forecasts 300.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: